JULIE HARMON: Open Payments
NPI 1013474733 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 28 payments from 18 companies in 2025. Trend: 2023 $723 · 2024 $847 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| GENZYME CORPORATION | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Eisai Inc. | 2 | $35 |
| Coherus Oncology, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
Products named: INLYTA, PLUVICTO, Enhertu, KEYTRUDA, Lenvima, IBRANCE, KEYTRUDA QLEX, LOQTORZI.
Industry payments across GA — which companies pay providers there.
